Dupixent 300 MG/2 ML pen 2ML
Ended Awarded
- Contract number
- SPE2DB26FMBFE
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $27,598
Award facts
- Contract value 100% obligated
- $27,597.66 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $27,597.66 on October 29, 2025, for Dupixent 300 mg/2 ml pen injectors with a firm fixed price structure and completion date of October 30, 2025. This competitively awarded contract, with no set-aside designation, represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) vehicle with DLA Troop Support Medical (SPE2DX), a $999.99 million comprehensive pharmaceutical supply contract running through December 2026. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania.
AmerisourceBergen, a major pharmaceutical distributor and critical federal healthcare vendor, supplies a diverse portfolio of medications and medical supplies to military and veteran healthcare systems through its DLA partnerships. Dupixent (dupilumab) is a specialty biologic medication used to treat moderate-to-severe atopic dermatitis, eosinophilic esophagitis, and moderate-to-severe asthma, making this delivery order consistent with the company's extensive track record of fulfilling federal procurement requirements for brand-name and specialty pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DB26FMBFE?
SPE2DB26FMBFE was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 29, 2025.
How much is contract SPE2DB26FMBFE worth?
The government has obligated $27,598 on SPE2DB26FMBFE.
Is contract SPE2DB26FMBFE an order under another contract?
Yes. SPE2DB26FMBFE is a delivery order under SPE2DB20D2104, an indefinite delivery contract.
Was contract SPE2DB26FMBFE competed?
The extent of competition for SPE2DB26FMBFE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award